SU1605914A3 - Способ стабилизации высокоочищенного фактора некроза опухоли из плазмы или сыворотки кролика, индуцированного липополисахаридами - Google Patents
Способ стабилизации высокоочищенного фактора некроза опухоли из плазмы или сыворотки кролика, индуцированного липополисахаридами Download PDFInfo
- Publication number
- SU1605914A3 SU1605914A3 SU833571944A SU3571944A SU1605914A3 SU 1605914 A3 SU1605914 A3 SU 1605914A3 SU 833571944 A SU833571944 A SU 833571944A SU 3571944 A SU3571944 A SU 3571944A SU 1605914 A3 SU1605914 A3 SU 1605914A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- factor
- activity
- globulin
- protamine
- tumor
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57129560A JPS5920225A (ja) | 1982-07-27 | 1982-07-27 | ガン壊死因子の安定化方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1605914A3 true SU1605914A3 (ru) | 1990-11-07 |
Family
ID=15012508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU833571944A SU1605914A3 (ru) | 1982-07-27 | 1983-04-05 | Способ стабилизации высокоочищенного фактора некроза опухоли из плазмы или сыворотки кролика, индуцированного липополисахаридами |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5920225A (https=) |
| SU (1) | SU1605914A3 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2629000B2 (ja) * | 1986-07-18 | 1997-07-09 | 中外製薬株式会社 | 安定な顆粒球コロニー刺激因子含有製剤 |
| KR102940220B1 (ko) * | 2021-02-08 | 2026-03-17 | 주식회사 대웅 | 장기 저장이 가능한 보툴리눔 독소 동결건조 제형 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55108821A (en) * | 1979-02-14 | 1980-08-21 | Kanebo Ltd | Preparation of antitumor agent |
-
1982
- 1982-07-27 JP JP57129560A patent/JPS5920225A/ja active Granted
-
1983
- 1983-04-05 SU SU833571944A patent/SU1605914A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5920225A (ja) | 1984-02-01 |
| JPH0375530B2 (https=) | 1991-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR860000842B1 (ko) | 종양 괴사 인자의 안정화 방법 | |
| US4824938A (en) | Water-soluble dry solid containing proteinaceous bioactive substance | |
| JP2512453B2 (ja) | 天然のコロニ−促進因子―1の精製 | |
| US3637640A (en) | Orgotein stabilized with saccharide process and products | |
| EP0090892B1 (en) | Process for the purification of physiologically active substance having antitumour activity | |
| JPS59137417A (ja) | 人尿由来コロニ−形成刺激因子及びカリクレインの製造法 | |
| JPH03505334A (ja) | 凍結乾燥されたペプチド製剤 | |
| JPS6019719A (ja) | 抗腫瘍活性を有する蛋白質 | |
| JPS63165328A (ja) | 組織タンパクpp4含有医薬 | |
| SU1605914A3 (ru) | Способ стабилизации высокоочищенного фактора некроза опухоли из плазмы или сыворотки кролика, индуцированного липополисахаридами | |
| JPH0713026B2 (ja) | 血友病a抑制患者の治療のための製剤及び該製剤の製造方法 | |
| US3579495A (en) | Isolation of orgotein from blood | |
| JP2566919B2 (ja) | α−インタ−フエロンの製造方法 | |
| JPS62185027A (ja) | 組換えインタ−ロイキン−2組成物およびその製造方法 | |
| JPH0222233A (ja) | スーパーオキシドディスムターゼ組成物 | |
| EP0539408A1 (en) | STABILIZED COMPOSITION CONTAINING A FIBROBLAST GROWTH FACTOR. | |
| KR970009890B1 (ko) | 혈소판감소증치료제 | |
| Kim et al. | Immobilization of urokinase on agarose matrices | |
| JPS5959625A (ja) | ガン壊死因子を安定化する方法 | |
| JPH04198195A (ja) | Cpb―iの安定化方法及び製剤組成物 | |
| JPH0375529B2 (https=) | ||
| JPH04187640A (ja) | 経口・経皮免疫機能促進剤、動物用経口・経皮免疫機能促進剤 | |
| EP0134247A1 (en) | Protein with oncostatic effect, process for its preparation, and oncostatic drug containing it | |
| EP0891778A2 (en) | Agents for the prevention and/or treatment of radiation-induced disorders | |
| US5023320A (en) | Process for the purification of physiologically active substance having antitumor activity |